GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,648.00
arrow_upward
+1.51%(+39.50) 1D
Nov 20, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
₹2,607.90
High
₹2,657.70
Low
₹2,601.90
Mkt. cap
747.33B
Avg. vol.
803.10K
Volume
540.17K
Dividend
0.19%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
41.58
52-wk high
₹2,714.00
52-wk low
₹1,825.10
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,607.90
High
₹2,657.70
Low
₹2,601.90
Mkt. cap
747.33B
Avg. vol.
803.10K
Volume
540.17K
Dividend
0.19%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
41.58
52-wk high
₹2,714.00
52-wk low
₹1,825.10
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
24/7 Wall St.
·
5 minutes ago
Jim Cramer Says the Market “Sliced Right Through” His S&P 500 Target
Traders Union
·
27 minutes ago
Seventeen of the twenty largest S&P 500 drops began below the 200-day moving average, Ryan Detrick notes
Yahoo Finance
·
3 hours ago
Chips suffer worst week since 2001 as the Nasdaq nears a bear market
Profile
Glenmark Pharmaceuticals Limited is an Indian pharmaceutical company with its headquarters in Mumbai. It was founded 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, and its shares are listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations mainly in India, North America, and Europe. It had about 17,000 employees as of March 2026. Its name comes from Saldanha's sons, Glenn and Mark.
Glenmark began developing proprietary medicines in the mid-2010s. In 2025, its research arm, Ichnos Glenmark Innovation, licensed ISB 2001, an investigational treatment for multiple myeloma, to AbbVie for an upfront payment of $700 million. The U.S. Food and Drug Administration has issued warning letters to several of the company's plants in India and the United States. Wikipedia
About Glenmark Pharmaceuticals Ltd
CEO-
Employees16.9K
FoundedNov 18, 1977
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteglenmarkpharma.com